Breaking News

  • 2 hours ago

  • Pharma Now Editorial Team

Anaveon Achieves Phase 1 Clinical Benefit Signal for ANV600 as Company Seeks Oncology Partners
Breaking News

More News

Lupin Gains FDA Establishment Inspection Report for Ankleshwar Facility Following Pre-Approval Inspection Closure

Lupin Gains FDA Establishment Inspection Report for Ankleshwar Facilit...

Pharma Now Editorial Team

Sanofi Gains FDA Priority Review for Venglustat in Gaucher Disease Type 3

Sanofi Gains FDA Priority Review for Venglustat in Gaucher Disease Typ...

Pharma Now Editorial Team

Novo Nordisk Presents Late-Stage Pipeline and Semaglutide Expansion Data at ADA 2026

Novo Nordisk Presents Late-Stage Pipeline and Semaglutide Expansion Da...

Pharma Now Editorial Team

Asahi Kasei Licenses DAR-Control ADC Platform to Advance Single- and Dual-Payload Conjugate Manufacturing

Asahi Kasei Licenses DAR-Control ADC Platform to Advance Single- and D...

Pharma Now Editorial Team

Ad
Advertisement

Interviews & Opinions

Article

“If You Want to Be a King, First Behave Like One” Naresh Kumar Gaur on Leadership & Ownership

Naresh Kumar Gaur says pharma titles follow behaviour, not the other way around. Why most professionals are waiting for a crown they have to earn firs...

FT - Mr. Naresh Kumar Gaur

Read More

Article
From ‘Why Reject?’ to ‘How Release?’: Deepak Kasbi on the Cultural Shift in Pharma Quality

FT - Mr. Deepak Kasbi

Article
Five Pillars Of Leadership That Built A Pharma Veteran: Shyam Khante’s 45-Year Pharma Journey

FT - Mr. Shyam Khante

Article
“Quality is Driven by Science” – Leadership Lessons from Zydus President Vikram Shukla

FT - Mr. Vikram Shukla

Ad
Advertisement
Ad

Pharma Shorts